{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:33:04Z","timestamp":1782930784137,"version":"3.54.5"},"reference-count":77,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.2010","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:36:40Z","timestamp":1749026200000},"page":"1-12","source":"Crossref","is-referenced-by-count":5,"title":["Therapies and nanotherapies for cervical cancer (Review)"],"prefix":"10.3892","volume":"23","author":[{"given":"Luz Victoria","family":"S\u00e1nchez\u2011Meza","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciresthel","family":"Bello\u2011Rios","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazm\u00edn","family":"G\u00f3mez\u2011G\u00f3mez","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Leyva\u2011V\u00e1zquez","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Esmeralda","family":"Araujo\u2011Arcos","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alfredo","family":"Villanueva Duque","sequence":"additional","affiliation":[{"name":"Mexican Social Security Institute, Family Medicine Unit No. 15, Clinical Coordination of Health Education and Research, Mexico City 04320, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Organista\u2011Nava","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Illades\u2011Aguiar","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biomedicine, Faculty of Chemical Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Guerrero 39090, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"key20250704084506_b1-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"e1125","key":"key20250704084506_b2-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1125","article-title":"Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells","volume":"1","author":"Kahue","year":"2018","journal-title":"Cancer Rep (Hoboken)"},{"key":"key20250704084506_b3-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.1128\/JVI.75.16.7583-7591.2001","article-title":"Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7","volume":"75","author":"Gonzalez","year":"2001","journal-title":"J Virol"},{"key":"key20250704084506_b4-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","article-title":"Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins","volume":"98","author":"Narisawa-Saito","year":"2007","journal-title":"Cancer Sci"},{"key":"key20250704084506_b5-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.1866","article-title":"HPV-mediated cervical carcinogenesis: Concepts and clinical implications","volume":"208","author":"Snijders","year":"2006","journal-title":"J Pathol"},{"key":"key20250704084506_b6-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/rmv.605","article-title":"Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins","volume":"19","author":"Yugawa","year":"2009","journal-title":"Rev Med Virol"},{"key":"key20250704084506_b7-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.antiviral.2016.03.016","article-title":"Gardasil-9: A global survey of projected efficacy","volume":"130","author":"Zhai","year":"2016","journal-title":"Antiviral Res"},{"issue":"3116","key":"key20250704084506_b8-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03116","article-title":"Human Papillomavirus E6 and E7: The cervical cancer hallmarks and targets for therapy","volume":"10","author":"Pal","year":"2020","journal-title":"Front Microbiol"},{"key":"key20250704084506_b9-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.currproblcancer.2018.01.016","article-title":"Chemotherapy and targeted therapy in the management of cervical cancer","volume":"42","author":"Kumar","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"key20250704084506_b10-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: From basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20250704084506_b11-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.arcmed.2009.06.001","article-title":"HPV-related carcinogenesis: Basic concepts, viral types and variants","volume":"40","author":"Lizano","year":"2009","journal-title":"Arch Med Res"},{"key":"key20250704084506_b12-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2174\/156800912799095135","article-title":"Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer","volume":"12","author":"Tan","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"key20250704084506_b13-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A gynecologic oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20250704084506_b14-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0140-6736(03)14023-8","article-title":"Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer","volume":"362","author":"Chang","year":"2003","journal-title":"Lancet"},{"key":"key20250704084506_b15-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/rmv.1825","article-title":"Nanotechnology in the management of cervical cancer","volume":"25 (Suppl 1)","author":"Chen","year":"2015","journal-title":"Rev Med Virol"},{"key":"key20250704084506_b16-BR-23-2-02010"},{"key":"key20250704084506_b17-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/cncr.30667","article-title":"Cervical cancer: A global health crisis","volume":"123","author":"Small","year":"2017","journal-title":"Cancer"},{"issue":"384","key":"key20250704084506_b18-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070384","article-title":"Key molecular events in cervical cancer development","volume":"55","author":"Balasubramaniam","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"200238","key":"key20250704084506_b19-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2022.200238","article-title":"Cervical cancer therapies: Current challenges and future perspectives","volume":"13","author":"Burmeister","year":"2022","journal-title":"Tumour Virus Res"},{"key":"key20250704084506_b20-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155 (Suppl 1)","author":"Bhatla","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"key20250704084506_b21-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ctrv.2008.05.006","article-title":"Chemotherapy for recurrent cervical cancer","volume":"34","author":"Pectasides","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"key20250704084506_b22-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/ijmr.IJMR_4454_20","article-title":"Updates on systemic therapy for cervical cancer","volume":"154","author":"Gopu","year":"2021","journal-title":"Indian J Med Res"},{"key":"key20250704084506_b23-BR-23-2-02010"},{"key":"key20250704084506_b24-BR-23-2-02010"},{"key":"key20250704084506_b25-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0975-7406.130965","article-title":"Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues","volume":"6","author":"Madaan","year":"2014","journal-title":"J Pharm Bioallied Sci"},{"key":"key20250704084506_b26-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1200\/JCO.23.00914","article-title":"First-Line pembrolizumab + chemotherapy versus placebo + chemotherapy for persistent, recurrent, or metastatic cervical cancer: Final overall survival results of KEYNOTE-826","volume":"41","author":"Monk","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20250704084506_b27-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ygyno.2013.04.009","article-title":"Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer","volume":"130","author":"Zighelboim","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key20250704084506_b28-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ygyno.2019.05.018","article-title":"Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer","volume":"154","author":"Suzuki","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"Cd006469","key":"key20250704084506_b29-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006469.pub2","article-title":"Chemotherapy for metastatic and recurrent cervical cancer","volume":"10","author":"Scatchard","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"e0340","key":"key20250704084506_b30-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010340","article-title":"The combination of cisplatin and topotecan as a second-line treatment for patients with advanced\/recurrent uterine cervix cancer","volume":"97","author":"Moon","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"key20250704084506_b31-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2009.26.9571","article-title":"Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer","volume":"28","author":"Monk","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20250704084506_b32-BR-23-2-02010","first-page":"2531","article-title":"Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence","volume":"5","author":"Segovia-Mendoza","year":"2015","journal-title":"Am J Cancer Res"},{"key":"key20250704084506_b33-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/1078-0432.CCR-07-4719","article-title":"Temsirolimus, an inhibitor of mammalian target of rapamycin","volume":"14","author":"Rini","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20250704084506_b34-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2217\/fon.11.116","article-title":"Pazopanib: A promising new agent in the treatment of soft tissue sarcomas","volume":"7","author":"Kasper","year":"2011","journal-title":"Future Oncol"},{"key":"key20250704084506_b35-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1634\/theoncologist.2009-0274","article-title":"(Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor","volume":"15","author":"Hamberg","year":"2010","journal-title":"Oncologist"},{"key":"key20250704084506_b36-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-biochem-052521-035949","article-title":"mRNA regulation by RNA modifications","volume":"92","author":"Gilbert","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"key20250704084506_b37-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"809","DOI":"10.4155\/tde-2016-0051","article-title":"Novel biodegradable nanocarriers for enhanced drug delivery","volume":"7","author":"Gagliardi","year":"2016","journal-title":"Ther Deliv"},{"issue":"880","key":"key20250704084506_b38-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070880","article-title":"Cationic liposomes carrying HPV16 E6-siRNA inhibit the proliferation, migration, and invasion of cervical cancer cells","volume":"16","author":"S\u00e1nchez-Meza","year":"2024","journal-title":"Pharmaceutics"},{"issue":"111270","key":"key20250704084506_b39-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111270","article-title":"Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer","volume":"196","author":"Dana","year":"2020","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"key20250704084506_b40-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.actbio.2015.04.021","article-title":"Functional-segregated coumarin-containing telodendrimer nanocarriers for efficient delivery of SN-38 for colon cancer treatment","volume":"21","author":"Xu","year":"2015","journal-title":"Acta Biomater"},{"key":"key20250704084506_b41-BR-23-2-02010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.procbio.2020.09.010","article-title":"Synergistically fabricated polymeric nanoparticles featuring dual drug delivery system to enhance the nursing care of cervical cancer","volume":"98","author":"Li","year":"2020","journal-title":"Process Biochem"},{"key":"key20250704084506_b42-BR-23-2-02010","author":"Paul"},{"key":"key20250704084506_b43-BR-23-2-02010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.smaim.2020.05.002","article-title":"Inorganic nano-carriers based smart drug delivery systems for tumor therapy","volume":"1","author":"Shi","year":"2020","journal-title":"Smart Mater Med"},{"key":"key20250704084506_b44-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1039\/c9tb02924a","article-title":"Gold nanoparticle-conjugated nanomedicine: Design, construction, and structure-efficacy relationship studies","volume":"8","author":"Wang","year":"2020","journal-title":"J Mater Chem B"},{"key":"key20250704084506_b45-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/10717544.2019.1667452","article-title":"Functionalized selenium nanoparticles for targeted siRNA delivery silence Derlin1 and promote antitumor efficacy against cervical cancer","volume":"27","author":"Xia","year":"2020","journal-title":"Drug Deliv"},{"key":"key20250704084506_b46-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2147\/IJN.S95611","article-title":"Anionic clay as the drug delivery vehicle: Tumor targeting function of layered double hydroxide-methotrexate nanohybrid in C33A orthotopic cervical cancer model","volume":"20","author":"Choi","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"1081","key":"key20250704084506_b47-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041081","article-title":"Effective delivery of arsenic trioxide to HPV-positive cervical cancer cells using optimised liposomes: A size and charge study","volume":"4","author":"Akhtar","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2156","key":"key20250704084506_b48-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092156","article-title":"Optimisation of folate-mediated liposomal encapsulated arsenic trioxide for treating HPV-positive cervical cancer cells in vitro","volume":"20","author":"Akhtar","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20250704084506_b49-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.msec.2018.09.044","article-title":"Synthesis of multifunctional Fe3O4@PLGA-PEG nano-niosomes as a targeting carrier for treatment of cervical cancer","volume":"94","author":"You","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"key20250704084506_b50-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/np960552o","article-title":"Biologically active acylglycerides from the berries of saw-palmetto (Serenoa repens)","volume":"60","author":"Shimada","year":"1997","journal-title":"J Nat Prod"},{"key":"key20250704084506_b51-BR-23-2-02010","first-page":"S165","article-title":"Anti-proliferative effect of long-chain monoglyceride derivatives on human cervical carcinoma cell line","volume":"100 (Suppl 8)","author":"Rongpan","year":"2017","journal-title":"J Med Assoc Thai"},{"key":"key20250704084506_b52-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.colsurfb.2018.12.062","article-title":"Encapsulation of monomyristin into polymeric nanoparticles improved its in vitro antiproliferative activity against cervical cancer cells","volume":"176","author":"Boondireke","year":"2019","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1327851","key":"key20250704084506_b53-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1327851","article-title":"Recent status and trends of nanotechnology in cervical cancer: A systematic review and bibliometric analysis","volume":"14","author":"Song","year":"2024","journal-title":"Front Oncol"},{"issue":"41","key":"key20250704084506_b54-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010041","article-title":"Nanomedicine in hepatocellular carcinoma: A new frontier in targeted cancer treatment","volume":"14","author":"Bakrania","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1065793","key":"key20250704084506_b55-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1065793","article-title":"Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"key":"key20250704084506_b56-BR-23-2-02010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/20550324.2024.2362504","article-title":"Navigating the novel nanoparticles: Current insights, innovations, and future vistas in detection and treatment of cervical cancer","volume":"10","author":"Devi","year":"2024","journal-title":"Nanocomposites"},{"key":"key20250704084506_b57-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00280-011-1574-3","article-title":"In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin\u2122)","volume":"68","author":"Canta","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"e13169","key":"key20250704084506_b58-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013169","article-title":"Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN)","volume":"97","author":"Xu","year":"2018","journal-title":"Medicina (Baltimore)"},{"issue":"897","key":"key20250704084506_b59-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12090897","article-title":"Liposomes co-encapsulating cisplatin\/mifepristone improve the effect on cervical cancer: In vitro and in vivo assessment","volume":"12","author":"Ledezma-Gallegos","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7290","key":"key20250704084506_b60-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27217290","article-title":"Preparation of paclitaxel-encapsulated bio-functionalized selenium nanoparticles and evaluation of their efficacy against cervical cancer","volume":"27","author":"Menon","year":"2022","journal-title":"Molecules"},{"key":"key20250704084506_b61-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2147\/IJN.S115136","article-title":"Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer","volume":"12","author":"Liu","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"key20250704084506_b62-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1039\/d3na00605k","article-title":"Hybrid AuNPs-3MPS-MTX nanosystem and its evaluation for treating cervical cancer and melanoma","volume":"5","author":"Hern\u00e1ndez-Esparza","year":"2023","journal-title":"Nanoscale Adv"},{"key":"key20250704084506_b63-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1021\/acs.molpharmaceut.6b01154","article-title":"Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment","volume":"14","author":"Lechanteur","year":"2017","journal-title":"Mol Pharm"},{"issue":"123","key":"key20250704084506_b64-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02583-y","article-title":"In vitro prototyping of a nano-organogel for thermo-sonic intra-cervical delivery of 5-fluorouracil-loaded solid lipid nanoparticles for cervical cancer","volume":"24","author":"Adeyemi","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"35223","key":"key20250704084506_b65-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1038\/srep35223","article-title":"Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma","volume":"6","author":"Reddy","year":"2016","journal-title":"Sci Rep"},{"key":"key20250704084506_b66-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"S727","DOI":"10.1080\/21691401.2018.1468770","article-title":"The combinational effect of E6\/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells","volume":"46 (Suppl 2)","author":"Javadi","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"key20250704084506_b67-BR-23-2-02010"},{"issue":"CD010870","key":"key20250704084506_b68-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010870.pub2","article-title":"Surgical treatment of stage IA2 cervical cancer","volume":"2014","author":"Kokka","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"575","key":"key20250704084506_b69-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030575","article-title":"Management of early-stage cervical cancer: A literature review","volume":"14","author":"Guimar\u00e3es","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20250704084506_b70-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.7150\/thno.41228","article-title":"Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy","volume":"7","author":"Xu","year":"2020","journal-title":"Theranostics"},{"key":"key20250704084506_b71-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.2147\/IJN.S117862","article-title":"Raspberry-like poly(\u03b3-glutamic acid) hydrogel particles for pH-dependent cell membrane passage and controlled cytosolic delivery of antitumor drugs","volume":"11","author":"Cho","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"1600279","key":"key20250704084506_b72-BR-23-2-02010","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201600279","article-title":"Nanoparticle functionalization and its potentials for molecular imaging","volume":"4","author":"Thiruppathi","year":"2016","journal-title":"Adv Sci (Weinh)"},{"key":"key20250704084506_b73-BR-23-2-02010","author":"Muhammad"},{"key":"key20250704084506_b74-BR-23-2-02010"},{"key":"key20250704084506_b75-BR-23-2-02010","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res Pharm Sci"},{"key":"key20250704084506_b76-BR-23-2-02010","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/pat.5263","article-title":"Natural and synthetic polymeric scaffolds used in peripheral nerve tissue engineering: Advantages and disadvantages","volume":"32","author":"Amini","year":"2021","journal-title":"Polym Adv Technol"},{"key":"key20250704084506_b77-BR-23-2-02010","author":"Degli Esposti"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:45:15Z","timestamp":1751607915000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.2010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,4]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.2010","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}